SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 151 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $133,230 | -40.2% | 75,699 | +6.6% | 0.00% | -50.0% |
| Q4 2022 | $222,959 | -53.1% | 71,006 | -26.9% | 0.00% | -55.6% |
| Q3 2022 | $475,000 | +446.0% | 97,115 | +361.0% | 0.01% | +350.0% |
| Q2 2022 | $87,000 | -82.2% | 21,068 | -74.9% | 0.00% | -84.6% |
| Q1 2022 | $488,000 | +373.8% | 83,973 | +632.4% | 0.01% | +333.3% |
| Q3 2021 | $103,000 | -75.3% | 11,465 | -57.1% | 0.00% | -89.3% |
| Q4 2020 | $417,000 | -70.9% | 26,700 | -80.0% | 0.03% | -82.3% |
| Q2 2019 | $1,434,000 | +52.1% | 133,199 | +34.8% | 0.16% | +1.9% |
| Q1 2019 | $943,000 | – | 98,800 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 916,153 | $8,740,000 | 1.27% |
| Casdin Capital, LLC | 1,080,000 | $10,303,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 843,957 | $8,051,000 | 0.94% |
| WASATCH ADVISORS LP | 6,437,908 | $61,418,000 | 0.67% |
| BB BIOTECH AG | 2,650,000 | $25,281,000 | 0.64% |
| Trellus Management Company, LLC | 30,000 | $286,000 | 0.54% |
| Opus Point Partners Management, LLC | 33,529 | $320,000 | 0.43% |
| SECTOR GAMMA AS | 238,857 | $2,279,000 | 0.36% |
| Leisure Capital Management | 37,656 | $359,000 | 0.30% |
| Ceeto Capital Group, LLC | 41,000 | $391,000 | 0.29% |